Respiratory syncytial virus seasonality, transmission zones, and implications for seasonal prevention strategy in China: a systematic analysis

被引:2
|
作者
Guo, Ling [1 ]
Deng, Shuyu [1 ]
Sun, Shiqi [1 ]
Wang, Xin [2 ,3 ]
Li, You [1 ,3 ,4 ]
机构
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Natl Vaccine Innovat Platform, Nanjing 211166, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Natl Vaccine Innovat Platform, Nanjing 211166, Peoples R China
[3] Univ Edinburgh, Usher Inst, Ctr Global Hlth, Edinburgh, Scotland
[4] Nanjing Med Univ, Changzhou Peoples Hosp 3, Changzhou Med Ctr, Changzhou, Peoples R China
来源
LANCET GLOBAL HEALTH | 2024年 / 12卷 / 06期
关键词
IMMUNIZATION; INFECTIONS; NIRSEVIMAB; INFANTS;
D O I
10.1016/S2214-109X(24)00090-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Respiratory syncytial virus (RSV) represents a substantial global health challenge, with a disproportionately high disease burden in low-income and middle-income countries. RSV exhibits seasonality in most areas globally, and a comprehensive understanding of within-country variations in RSV seasonality could help to define the timing of RSV immunisation programmes. This study focused on China, and aimed to describe the geographical distribution of RSV seasonality, identify distinct RSV transmission zones, and evaluate the potential suitability of a seasonal RSV prevention strategy. Methods We did a systematic analysis of RSV seasonality in China, with use of data on RSV activity extracted from a systematic review of studies published on Embase, MEDLINE, Web of Science, China National Knowledge Infrastructure, Wanfang Data, Chongqing VIP Information, and SinoMed, from database inception until May 5, 2023. We included studies of any design in China reporting at least 25 RSV cases, which aggregated RSV case number by calendar month or week at the province level, and with data covering at least 12 consecutive months before the year 2020 (prior to the COVID-19 pandemic). Studies that used only serology for RSV testing were excluded. We also included weekly data on RSV activity from open-access online databases of the Taiwan National Infection Disease Statistics System and Hong Kong Centre for Health Protection, applying the same eligiblity requirements. Across all datasets, we excluded data on RSV activity from Jan 1, 2020, onwards. We estimated RSV seasonal epidemic onset and duration using the annual average percentage (AAP) approach, and summarised seasonality at the provincial level. We used Pearson's partial correlation analysis to assess the correlation between RSV season duration and the latitude and longitude of the individual provinces. To define transmission zones, we used two independent approaches, an infant-passive-immunisation-driven approach (the moving interval approach, 6-month interval) and a data-driven approach (k-means), to identify groups of provinces with similar RSV seasonality. The systematic review was registered on PROSPERO, CRD42022376993. Findings A total of 157 studies were included along with the two online datasets, reporting data on 194 596 RSV cases over 442 study-years (covering the period from Jan 1, 1993 to Dec 31, 2019), from 52 sites in 23 provinces. Among 21 provinces with sufficient data (>= 100 reported cases), the median duration of RSV seasonal epidemics was 4.6 months (IQR 4.1-5.4), with a significant latitudinal gradient (r=-0.69, p<0.0007), in that provinces on or near the Tropic of Cancer had the longest epidemic duration. We found no correlation between longitude and epidemic duration (r=-0>15, p=0.53). 15 (71%) of 21 provinces had RSV epidemics from November to March. 13 (62%) of 21 provinces had clear RSV seasonality (epidemic duration <= 5 months). The moving interval approach categorised the 21 provinces into four RSV transmission zones. The first zone, consisting of five provinces (Fujian, Guangdong, Hong Kong, Taiwan, and Yunnan), was assessed as unsuitable for seasonal RSV immunisation strategies; the other three zones were considered suitable for seasonal RSV immunisation strategies with the optimal start month varying between September (Hebei), October (Anhui, Chongqing, Henan, Hubei, Jiangsu, Shaanxi, Shandong, Shanghai, Sichuan, and Xinjiang), and November (Beijing, Gansu, Guizhou, Hunan, and Zhejiang). The k-means approach identified two RSV transmission zones, primarily differentiated by whether the province was on or near the Tropic of Cancer (Fujian, Guangdong, Hong Kong, Taiwan, Yunan, and Hunan) or not (the remaining 15 provinces). Interpretation Although substantial variations in RSV seasonality were observed across provinces of China, our study identified distinct transmission zones with shared RSV circulating patterns. These findings could have important implications for decision making on RSV passive immunisation strategy. Furthermore, the methodological framework in this study for defining RSV seasons and identifying RSV transmission zones is potentially applicable to other countries or regions.
引用
收藏
页码:e1005 / e1016
页数:12
相关论文
共 50 条
  • [1] Respiratory syncytial virus seasonality in China: implications for intervention
    Ren, Lili
    Li, Zhongjie
    [J]. LANCET GLOBAL HEALTH, 2024, 12 (06):
  • [2] Respiratory syncytial virus seasonality and its implications on prevention strategies
    Janet, Sophie
    Broad, Jonathan
    Snape, Matthew D.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) : 234 - 244
  • [3] Respiratory syncytial virus seasonality in three epidemiological zones of Kenya
    Rose, Erica Billig
    Nyawanda, Bryan O.
    Munywoki, Patrick K.
    Murunga, Nickson
    Bigogo, Godfrey M.
    Otieno, Nancy A.
    Onyango, Clayton
    Chaves, Sandra S.
    Verani, Jennifer R.
    Emukule, Gideon O.
    Widdowson, Marc-Alain
    Nokes, D. James
    Gerber, Susan, I
    Langley, Gayle E.
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (02) : 195 - 201
  • [4] Sewage surveillance revealed the seasonality and prevalence of respiratory syncytial virus and its implications for seasonal immunization strategy in low and middle-income regions of China
    Zhang, Ziqiang
    Li, Qingxiang
    He, Fenglan
    Wang, Zengguo
    Zhu, Chulong
    Tu, Junling
    Li, Haifeng
    Yi, Liu
    Deng, Yao
    Fu, Songzhe
    [J]. Water Research, 2025, 270
  • [5] Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis
    Deng, Shuyu
    Guo, Ling
    Cohen, Cheryl
    Meijer, Adam
    Moyes, Jocelyn
    Pasittungkul, Siripat
    Poovorawan, Yong
    Teirlinck, Anne
    van Boven, Michiel
    Wanlapakorn, Nasamon
    Wolter, Nicole
    Paget, John
    Nair, Harish
    Li, You
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2024, 229 : S25 - S33
  • [6] The impact of the 2009 influenza pandemic on the seasonality of human respiratory syncytial virus: A systematic analysis
    Li, You
    Wang, Xin
    Msosa, Takondwa
    de Wit, Femke
    Murdock, Jayne
    Nair, Harish
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (06) : 804 - 812
  • [7] Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis
    Hon, Kam Lun
    Leung, Ting Fan
    Cheng, Wing Yee
    Ko, Natalie Man Wai
    Tang, Wing Ki
    Wong, Win Win
    Yeung, Wan Hang Prisca
    Chan, Paul K. S.
    [J]. JOURNAL OF CRITICAL CARE, 2012, 27 (05) : 464 - 468
  • [8] Respiratory Syncytial Virus Seasonality, Beijing, China, 2007-2015
    Yu, Jianxing
    Liu, Chunyan
    Xiao, Yan
    Xiang, Zichun
    Zhou, Hongli
    Chen, Lan
    Shen, Kunling
    Xie, Zhengde
    Ren, Lili
    Wang, Jianwei
    [J]. EMERGING INFECTIOUS DISEASES, 2019, 25 (06) : 1127 - 1135
  • [9] Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program
    Lavergne, V.
    Ghannoum, M.
    Weiss, K.
    Roy, J.
    Beliveau, C.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 (01) : 137 - 142
  • [10] Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program
    V Lavergne
    M Ghannoum
    K Weiss
    J Roy
    C Béliveau
    [J]. Bone Marrow Transplantation, 2011, 46 : 137 - 142